Highbridge Capital Management’s Cartesian Growth Corp II RENE Stock Holding History
Bought
Maintained
Sold
Other funds holding RENE
CF
WCMNY
LP
PAMP
AA
Highbridge Capital Management's RENE Position: Q1 2023 in Review
Highbridge Capital Management sold out of Cartesian Growth Corp II (RENE) in Q1 2023, closing a stake of 1,498,671 shares — an estimated $15.4M sold.
Highbridge Capital Management first reported a position in RENE in Q3 2022 and held it in 2 quarters. The position peaked at $20.7M in Q3 2022. 50 funds tracked by Wall St. Rank hold RENE as of Q1 2023.
- Highbridge Capital Management reported no remaining Cartesian Growth Corp II position as of Q1 2023 after selling out during the quarter.
- Highbridge Capital Management sold 1,498,671 Cartesian Growth Corp II shares in Q1 2023, an estimated $15.4M.
- Highbridge Capital Management first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 2 quarters.
- Highbridge Capital Management's Cartesian Growth Corp II position peaked at $20.7M in Q3 2022.
- 50 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q1 2023.
Based on Highbridge Capital Management's 13F filing for Q1 2023, filed 11 May 2023.